​Genomize is a global innovator in bioinformatics, delivering advanced digital solutions for NGS data analysis. With a strong foundation in genome-level analytics, the company develops high-end platforms that transform complex sequencing data into clinically meaningful insights. Their flagship SEQ Platform enables seamless end-to-end analysis, supporting accurate variant interpretation through standardized ACMG classification. Designed for both clinical and research applications, Genomize empowers users to make confident, data-driven decisions and improve patient outcomes.